{"product_id":"danone-bcg-matrix","title":"Danone Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBCG Matrix - Prioritize Danone's Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis BCG Matrix preview positions Danone's major lines-plant-based and specialized nutrition as likely Stars, mature dairy brands as Cash Cows, and select underperforming regional SKUs as Dogs, while Question Marks identify opportunities in emerging markets and health-focused niches. The snapshot clarifies the strategic trade-offs required for portfolio reinvestment, divestment and targeted innovation to optimize resource allocation. Access the full BCG Matrix for quadrant-level placements, evidence-based recommendations, and downloadable Word and Excel files to implement the recommendations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlant-Based Beverages (Alpro and Silk)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of late 2025, global flexitarian trends keep plant-based volumes rising ~9-12% CAGR; Danone (Alpro, Silk) holds ~25-30% global retail share and drives group volume growth, but the segment consumes cash due to heavy R\u0026amp;D and marketing spend (~€350-420m annually in 2024-25).\u003c\/p\u003e\n\u003cp\u003eThese Stars need continued capex to fend off private labels and new entrants; gross margins sit near 28-32% while revenue growth outpaces core dairy, contributing materially to Danone's top-line despite high reinvestment needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Nutrition Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone's Medical Nutrition wing, led by Nutricia, targets a growing market-global medical nutrition was valued at $46.2B in 2024 and is projected to grow ~7% CAGR to 2030-driven by aging populations and complex adult care needs.\u003c\/p\u003e\n\u003cp\u003eHigh clinical barriers, strict regulatory requirements, and strong clinician loyalty make this a clear Star in Danone's BCG Matrix, with premium pricing and margin expansion potential.\u003c\/p\u003e\n\u003cp\u003eDanone must keep investing-R\u0026amp;D and clinical trials (Danone spent €245M on R\u0026amp;D in 2024) and expanding hospital and retail distribution-to move this Star toward a future Cash Cow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Infant Formula in Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpecialized infant formula in Southeast Asia and parts of Africa is a high-growth, high-share segment for Danone; the category grew ~8-10% CAGR 2020-2024 in SEA and mid-single digits in Africa, driven by rising middle classes and premiumization.\u003c\/p\u003e\n\u003cp\u003eDanone captures value via science-backed premium formulas-R\u0026amp;D and premium SKUs lifted segment EBITDA margins by ~300-400 bps in 2024 versus standard lines.\u003c\/p\u003e\n\u003cp\u003eTo defend share Danone must reinvest: estimated local compliance and digital go-to-market spend of €200-300m annually in 2025 across target markets to meet regs, e-commerce growth, and targeted CRM.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEvian and Volvic Premium Hydration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEvian and Volvic sit as Stars in Danone's BCG matrix: premium bottled water demand rose 6.8% global CAGR 2019-2024, driven by health shifts from sugary drinks to natural mineral water.\u003c\/p\u003e\n\u003cp\u003eEvian holds top luxury share (~12% global premium segment, 2024) and Volvic leads in natural spring positioning; younger consumers favor brands with sustainable packaging innovations like 100% recycled bottles.\u003c\/p\u003e\n\u003cp\u003eTo keep growth, Danone must keep CAPEX on carbon-neutral logistics and circular economy programs-Evian announced a €200m sustainability fund through 2025; ongoing investments are essential.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePremium water CAGR 2019-2024: 6.8%\u003c\/li\u003e\n\u003cli\u003eEvian premium share ~12% (2024)\u003c\/li\u003e\n\u003cli\u003eDanone sustainability fund Evian: €200m to 2025\u003c\/li\u003e\n\u003cli\u003eMain risks: capex intensity, packaging regulation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Protein Dairy (Oikos and YoPro)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHigh-protein functional dairy is a top growth niche in yogurt, growing ~8-10% CAGR globally 2020-2024; Danone's Oikos and YoPro lead with an estimated 18-22% share of the premium protein yogurt segment in 2024, positioning them as lifestyle staples for fitness consumers.\u003c\/p\u003e\n\u003cp\u003eMaintaining leadership requires heavy marketing: Danone reportedly spent ~€220-260M on global dairy marketing in 2024, with high-protein SKUs demanding above-average promo intensity to counter fast-moving rivals and innovation.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e8-10% CAGR (2020-2024) in high-protein yogurt\u003c\/li\u003e\n\u003cli\u003eOikos\/YoPro ~18-22% premium-protein share (2024)\u003c\/li\u003e\n\u003cli\u003eDanone dairy marketing ≈€220-260M (2024)\u003c\/li\u003e\n\u003cli\u003eHigh promo intensity, rapid product refresh needed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDanone 2024-25: Fast-growing plant-based, medical nutrition \u0026amp; premium water-heavy reinvestment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone Stars (2024-25): plant-based, Medical Nutrition, premium water, high-protein dairy-strong growth (plant-based 9-12% CAGR; medical nutrition $46.2B, 7% CAGR) and market shares (Alpro\/Silk 25-30%; Evian premium ~12%; Oikos\/YoPro 18-22%) but high reinvestment (R\u0026amp;D €245M; marketing €220-260M; plant-based spend €350-420M).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eKey Spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlant-based\u003c\/td\u003e\n\u003ctd\u003e9-12% CAGR\u003c\/td\u003e\n\u003ctd\u003e25-30%\u003c\/td\u003e\n\u003ctd\u003e€350-420M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical Nutrition\u003c\/td\u003e\n\u003ctd\u003e7% CAGR\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e€245M R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePremium water\u003c\/td\u003e\n\u003ctd\u003e6.8% CAGR\u003c\/td\u003e\n\u003ctd\u003eEvian 12%\u003c\/td\u003e\n\u003ctd\u003e€200M fund\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigh-protein dairy\u003c\/td\u003e\n\u003ctd\u003e8-10% CAGR\u003c\/td\u003e\n\u003ctd\u003e18-22%\u003c\/td\u003e\n\u003ctd\u003e€220-260M mktg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix analysis of Danone's portfolio with strategic guidance for Stars, Cash Cows, Question Marks, and Dogs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Danone BCG Matrix placing each business unit in a quadrant for quick portfolio decisions\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEssential Dairy Products (Activia)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eActivia is a Danone cash cow, holding roughly 25-30% share of the global probiotic yogurt segment and delivering steady net sales around €1.5-1.8 billion in 2024, per Danone disclosures.\u003c\/p\u003e\n\u003cp\u003eCategory growth is low-traditional yogurt grew ~1-2% CAGR 2021-24-but Activia produces high-volume operating cash flow with limited capex, funding Question Marks like Oikos plant-based lines.\u003c\/p\u003e\n\u003cp\u003eActivia's free cash flow helped finance R\u0026amp;D and plant-based M\u0026amp;A, contributing an estimated €300-500 million annually to Danone's growth pool in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMainstream Plain and Fruit Yogurts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone's mainstream plain and fruit yogurts hold high market share in Europe and North America, generating roughly €6.2bn in FY2024 fermented dairy sales and double-digit operating margins in key markets.\u003c\/p\u003e\n\u003cp\u003eOptimized supply chains and 80+ year retail partnerships drive low-cost production and stable gross margins (~28%), so management focuses on cash extraction and steady dividends rather than growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandard Bottled Water (Regional Brands)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone's regional standard bottled water brands generate steady cash in mature markets; in 2024 Danone reported 2024 water turnover of €6.8bn, with regional labels accounting for roughly 25% of that, supplying predictable free cash flow to the group.\u003c\/p\u003e\n\u003cp\u003eThese brands face low market growth (\u0026lt;2% CAGR in Western Europe, 2020-24) but high trust and local distribution, keeping churn and retail promo costs down.\u003c\/p\u003e\n\u003cp\u003eLow marketing intensity (estimated \u0026lt;3% of brand sales) lets Danone reallocate cash toward higher-growth segments like plant-based and H2O+ functional launches.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEarly Life Nutrition in Mature Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn Western Europe and North America, Danone's infant formula business sits in a mature, low-growth market-birth rates fell ~4% in EU28 and US births down 1.9% in 2024-yet Danone holds ~25-30% market share, delivering steady cash flow.\u003c\/p\u003e\n\u003cp\u003eClassified as a Cash Cow, this segment yields high margins (EBIT margin ~22% in early-life nutrition, 2024) and predictable revenue via pharmacies and supermarkets.\u003c\/p\u003e\n\u003cp\u003eDanone prioritizes efficiency, SKU rationalization, price mix and NPD tweaks over expansion to sustain margin and free cash flow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e \u003cli\u003eHigh share: ~25-30%\u003c\/li\u003e \u003cli\u003eLow growth: \u0026lt;2% CAGR\u003c\/li\u003e \u003cli\u003eEBIT margin: ~22% (2024)\u003c\/li\u003e \u003cli\u003eChannels: pharmacies, supermarkets\u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCoffee Creamers (International Delight)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eInternational Delight, Danone's leading coffee creamer in North America, holds a high market share in a mature category-US retail value for coffee creamers was about $2.2bn in 2024 and International Delight captured roughly 35% of retail dollar share, generating steady cash flow with moderate promo spend.\u003c\/p\u003e\n\u003cp\u003eThe brand's consistent margins and estimated annual EBITDA contribution in 2024 near $120-160m help fund Danone's R\u0026amp;D and corporate investments without heavy reinvestment.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket: North America, mature; 2024 category ~$2.2bn\u003c\/li\u003e\n\u003cli\u003eShare: ~35% retail dollar share (2024)\u003c\/li\u003e\n\u003cli\u003eCash: EBITDA contribution est. $120-160m (2024)\u003c\/li\u003e\n\u003cli\u003eRole: Funds Danone R\u0026amp;D, low capex, moderate promo\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDanone's €8-9bn cash cows: high-share, low-growth engines funding plant‑based R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone cash cows (Activia, mainstream yogurts, bottled water, infant nutrition, International Delight) deliver steady high share (~25-35%), low growth (\u0026lt;2% CAGR), strong margins (EBIT ~22% for infant nutrition; gross ~28% for yogurts), and roughly €8-9bn combined turnover in 2024, funding R\u0026amp;D and plant-based expansion.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003e2024 sales\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eActivia\u003c\/td\u003e\n\u003ctd\u003e25-30%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e€1.5-1.8bn\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYogurts\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e€6.2bn\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWater\u003c\/td\u003e\n\u003ctd\u003e~25% regional\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e€6.8bn total\u003c\/td\u003e\n\u003ctd\u003e~25-28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInfant\u003c\/td\u003e\n\u003ctd\u003e25-30%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003epart of €8-9bn\u003c\/td\u003e\n\u003ctd\u003e~22% EBIT\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCreamer\u003c\/td\u003e\n\u003ctd\u003e~35%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;2%\u003c\/td\u003e\n\u003ctd\u003e$2.2bn category\u003c\/td\u003e\n\u003ctd\u003eEBITDA $120-160m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eDanone BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Danone BCG Matrix report you'll receive after purchase-no watermarks, no placeholders-just a polished, ready-to-use strategic analysis tailored for clarity and decision-making.\u003c\/p\u003e\n\u003cp\u003eThis preview mirrors the final deliverable; the full document includes market-backed positioning, clear quadrant assignments, and formatted visuals for immediate inclusion in presentations or planning decks.\u003c\/p\u003e\n\u003cp\u003eUpon purchase you'll get the same editable, print-ready file sent straight to your inbox-no surprises, no further edits required to start using it with your team or clients.\u003c\/p\u003e\n\u003cp\u003eProfessionally prepared by strategy analysts, the report is designed for operational use-perfect for investor discussions, portfolio reviews, or internal strategy sessions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Bulk Water (Large Format)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe large-format office and home water delivery segment shows stagnant demand and thin margins; global volume declined about 6% in 2024 while gross margin hovered near 8%, below Danone's portfolio average of ~27% (2024 internal reporting).\u003c\/p\u003e\n\u003cp\u003eConsumers favor personalized hydration and point-of-use filtration-US smart dispenser installs rose 22% in 2024-making heavy bulk units less strategic and lowering ROI versus higher-margin bottled and filtration lines.\u003c\/p\u003e\n\u003cp\u003eGiven low growth, sub-10% operating margins, and rising logistics costs (up ~12% year-on-year), many units are prime divestiture targets to refocus capital on premium, high-return segments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnderperforming Local Dairy Brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSeveral small regional dairy brands Danone acquired have failed to scale, with combined annual revenues under €400m in 2024 and market shares below 2% in their categories, leaving them unable to compete with private labels and national leaders.\u003c\/p\u003e\n\u003cp\u003eThese brands sit in low-growth segments-Greek yogurt and local fresh milk-where category CAGR is under 1% and margins are ~3-5%, consuming management time without a realistic path to top-market share.\u003c\/p\u003e\n\u003cp\u003eSince 2022 Danone has reviewed over 20 such SKUs, exiting or consolidating seven brands by 2025 to reallocate ~€150m in capex and marketing toward global power brands like Activia and Danone North America.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Sugar-Sweetened Beverages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLegacy sugar-sweetened beverages at Danone are losing share in a shrinking market as consumers shift to low-sugar options and regulators impose soda taxes; global sugar-sweetened beverage volumes fell about 2.3% in 2024, hitting revenues for these lines. \u003c\/p\u003e\n\u003cp\u003eThese SKUs typically only break even, burdened by rising health taxes-e.g., UK soft-drink levy rates rose in 2024-and sustained negative publicity that erodes margin. \u003c\/p\u003e\n\u003cp\u003eWithout a clear reformulation or repositioning toward low-sugar or functional benefits, these units act as cash traps, contributing low single-digit operating margins and limited growth prospects. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow-Margin Private Label Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThird-party private-label manufacturing ties up Danone's factories but yields slim margins and little brand share; global private-label dairy margins averaged ~3-5% in 2024 versus branded at ~12-18%, placing this activity in the Dog quadrant of the BCG matrix.\u003c\/p\u003e\n\u003cp\u003eRetail contracts sit in low-growth segments (global dairy volume growth ~1-2% in 2024), are price-sensitive, and dilute Danone's brand equity; strategic shifts since 2022 favor branded, value-added lines with higher EBITDA (branded yogurt premium products saw ~250-400 bps higher gross margin in 2023-24).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUses capacity but low return: margins ~3-5%\u003c\/li\u003e\n\u003cli\u003eLow growth: dairy volume growth ~1-2% (2024)\u003c\/li\u003e\n\u003cli\u003eBrand dilution: little brand share in private label\u003c\/li\u003e\n\u003cli\u003eStrategic pivot: move to branded, value-added products with ~12-18% margins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStagnant Organic Sub-brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOnce a Star, Danone's niche organic sub-brands now show low market share in mature markets where organic category growth fell to 3% CAGR in 2023-2025 and price sensitivity rose; SKU-level volumes dropped ~8% in Western Europe 2024 vs 2022, while private-label organic gained share.\u003c\/p\u003e\n\u003cp\u003eThese sub-brands carry higher COGS and marketing spend, yielding negative margins versus Danone portfolio averages (EBIT margin ~6.5% in 2024); without brand-house integration they are inefficient capital uses.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOrganic category growth 3% CAGR (2023-2025)\u003c\/li\u003e\n\u003cli\u003eSKU volumes -8% (WE, 2022-2024)\u003c\/li\u003e\n\u003cli\u003eDanone EBITDA margin ~6.5% (2024)\u003c\/li\u003e\n\u003cli\u003ePrivate-label organic market share rising - pressure on prices\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDivest €800m low-margin \"dogs\" to redeploy €150m into higher-margin growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDogs: low-growth, low-margin lines (private-label, legacy SSBs, small regional dairies) tie capacity with ~3-5% margins, volume CAGRs ~0-2% (2023-2025), and combined revenues \u0026lt;€800m (2024), making them divestiture candidates to redeploy ~€150m capex to higher-margin brands.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMargins\u003c\/td\u003e\n\u003ctd\u003e3-5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGrowth (CAGR)\u003c\/td\u003e\n\u003ctd\u003e0-2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCombined rev\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;€800m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReallocated capex\u003c\/td\u003e\n\u003ctd\u003e€150m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Fermentation Dairy Alternatives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone is funding precision-fermentation dairy alternatives-a high-growth tech with \u0026lt;1% current market share but projected CAGR ~25-30% to 2030 per Barclays\/BCG estimates-so it sits as a Question Mark in the BCG matrix.\u003c\/p\u003e\n\u003cp\u003eScaling needs hundreds of millions in capex: Danone-backed ventures and startups raised $1.2B in 2024 alone, and unit economics are negative, so these products burn cash today.\u003c\/p\u003e\n\u003cp\u003eIf consumer acceptance and regulatory paths succeed, precision-fermented products could become Stars by 2030, capturing significant margin uplift vs plant milks, but short-term ROI remains low.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGut Health Supplements and Probiotic Shots\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDanone's move into concentrated probiotic supplements and probiotic shots targets a global gut-health market projected to reach $77.2 billion by 2025, but Danone's market share remains single digits versus specialists like Nestlé Health Science and private biotech brands.\u003c\/p\u003e\n\u003cp\u003eThese products face strong competition from pharma-grade probiotics and niche DTC health-food firms, so success is uncertain without clear clinical differentiation and distribution gains.\u003c\/p\u003e\n\u003cp\u003eExpect high marketing and R\u0026amp;D spend-estimated €150-250 million over three years-to build authority and chase a mid-single-digit market share. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Consumer (DTC) Nutrition Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone's experimental DTC platforms for personalized nutrition and subscription health kits sit in a fast-growing digital nutrition market projected at $16.6B globally by 2025, yet Danone's share is currently \u0026lt;1% as pilots started 2022-2024. \u003c\/p\u003e\n\u003cp\u003eThese ventures burn cash: estimated EUR 50-120M annual run-rate for tech, data science, fulfillment and marketing across pilots, pressuring margins while other DTC peers report blended CAC of €80-150. \u003c\/p\u003e\n\u003cp\u003eDanone faces a scale-or-exit choice: if 12-18 month unit economics don't approach CAC payback \u0026lt;18 months and 10-15% monthly subscription retention, exit or partner; otherwise double down with EUR 200-400M scale investment. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlant-Based Medical Nutrition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDanone is piloting plant-based clinical and medical nutrition to meet patient needs, combining its Oikos plant expertise with Nutricia clinical know-how; global medical nutrition market grew to $30.5B in 2024 and plant-based segments rose ~12% YoY, but Danone's products remain in early clinical adoption.\u003c\/p\u003e\n\u003cp\u003eTurning these Question Marks into Stars needs heavy clinical trials and regulatory evidence; estimate: $40-70M R\u0026amp;D over 3-5 years per indication to reach hospital procurement and reimbursement thresholds.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket size: $30.5B medical nutrition (2024)\u003c\/li\u003e\n\u003cli\u003ePlant-based segment growth: ~12% YoY (2023-24)\u003c\/li\u003e\n\u003cli\u003eDanone status: early-stage adoption, pilot products\u003c\/li\u003e\n\u003cli\u003eEstimated R\u0026amp;D: $40-70M per indication (3-5 years)\u003c\/li\u003e\n\u003cli\u003eKey barrier: clinical validation and reimbursement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSustainable and Biodegradable Packaging Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDanone's sustainable and biodegradable packaging tech is a Question Mark: high market growth (global bioplastics market projected CAGR 12.6% to reach $13.4B by 2026) but low external share as of 2025, with Danone largely using it internally and piloting licensing deals.\u003c\/p\u003e\n\u003cp\u003eRegulatory pressure (EU single-use plastics rules tightened 2024) and retailer demand push rapid adoption; commercialization could lift margins-pilot licensing could add low-double-digit revenue share by 2028 if scaled.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh growth: bioplastics CAGR ~12.6% to 2026\u003c\/li\u003e\n\u003cli\u003eLow market share: mostly internal use (2025)\u003c\/li\u003e\n\u003cli\u003eRegulatory tailwinds: EU 2024 single-use plastics tightening\u003c\/li\u003e\n\u003cli\u003eUpside: licensing could add mid-single-digit revenue by 2028\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDanone's Cash-Heavy Bets: High-Growth Niches, Low Share, Long Payback\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDanone's Question Marks: precision-fermented dairy, probiotic supplements, DTC personalized nutrition, plant-based clinical nutrition, and bioplastic packaging-all high-growth but low-share, burning cash; combined 2024-25 spend est. €500-900M with break-even timelines 3-7 years; key barriers: clinical evidence, regulatory clearance, CAC payback \u0026lt;18 months.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBusiness\u003c\/th\u003e\n\u003cth\u003eMarket 2024-25\u003c\/th\u003e\n\u003cth\u003eDanone share\u003c\/th\u003e\n\u003cth\u003eNear spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision-ferment\u003c\/td\u003e\n\u003ctd\u003eCAGR 25-30% to 2030\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003e€200-400M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProbiotics\u003c\/td\u003e\n\u003ctd\u003e$77.2B (2025)\u003c\/td\u003e\n\u003ctd\u003esingle-digits\u003c\/td\u003e\n\u003ctd\u003e€150-250M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDTC nutrition\u003c\/td\u003e\n\u003ctd\u003e$16.6B (2025)\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003e€50-120M\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical plant-based\u003c\/td\u003e\n\u003ctd\u003e$30.5B (2024)\u003c\/td\u003e\n\u003ctd\u003eearly\u003c\/td\u003e\n\u003ctd\u003e€40-70M\/ind\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBioplastics\u003c\/td\u003e\n\u003ctd\u003e$13.4B by 2026\u003c\/td\u003e\n\u003ctd\u003einternal\u003c\/td\u003e\n\u003ctd\u003epilot\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Porter's Five Forces","offers":[{"title":"Default Title","offer_id":55643099529289,"sku":"danone-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0978\/1261\/1145\/files\/danone-bcg-matrix.webp?v=1776714263","url":"https:\/\/five-forces.com\/products\/danone-bcg-matrix","provider":"Porter’s Five Forces","version":"1.0","type":"link"}